{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T23:28:38Z","timestamp":1783207718139,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","brachyjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.brachy.2024.11.003","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T21:07:28Z","timestamp":1733519248000},"page":"162-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and dosimetric outcomes of a 3-fraction high-dose-rate brachytherapy boost for the treatment of locally advanced cervical cancer in a safety net hospital"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1183-724X","authenticated-orcid":false,"given":"Karen","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9186-4987","authenticated-orcid":false,"given":"Samuel","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0115-8522","authenticated-orcid":false,"given":"Zichen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-6446","authenticated-orcid":false,"given":"Hye Ri","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick","family":"Lock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5466-8810","authenticated-orcid":false,"given":"Omar","family":"Ragab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3040-2540","authenticated-orcid":false,"given":"Andrew","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6451-7209","authenticated-orcid":false,"given":"Fahad","family":"Momin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2024.11.003_bib0001","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.brachy.2024.11.003_bib0002","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.brachy.2024.11.003_bib0003","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.brachy.2024.11.003_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172548","article-title":"Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States","volume":"12","author":"Yoo","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.brachy.2024.11.003_bib0005","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3322\/caac.21695","article-title":"Cancer statistics for the US Hispanic\/Latino population, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.brachy.2024.11.003_bib0006","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(01)05965-7","article-title":"Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis","volume":"358","author":"Green","year":"2001","journal-title":"The Lancet"},{"key":"10.1016\/j.brachy.2024.11.003_bib0007","unstructured":"NCCN Guidelines: Cervical Cancer. NCCN. Available at https:\/\/www.nccn.org\/guidelines\/guidelines-detail. Accessed March 5, 2024."},{"key":"10.1016\/j.brachy.2024.11.003_bib0008","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0360-3016(91)90143-R","article-title":"Tumor and treatment factors improving outcome in stage III-B cervix cancer","volume":"20","author":"Lanciano","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.003_bib0009","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijrobp.2023.11.007","article-title":"Updated trends in the utilization of brachytherapy in cervical cancer in the United States: A surveillance, epidemiology, and end-results study","volume":"119","author":"Han","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.003_bib0010","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijrobp.2014.07.017","article-title":"National cancer data base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements","volume":"90","author":"Gill","year":"2014","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2024.11.003_bib0011","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brachy.2011.07.002","article-title":"American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.11.003_bib0012","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0360-3016(98)00387-3","article-title":"Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule?","volume":"43","author":"Petereit","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.003_bib0013","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.brachy.2022.12.005","article-title":"Outcomes from a 3-fraction high-dose-rate brachytherapy regimen for patients with cervical cancer","volume":"22","author":"Williamson","year":"2023","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.11.003_bib0014","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ijrobp.2024.06.011","article-title":"Clinical outcomes of 3 versus 4 fractions of magnetic resonance image-guided brachytherapy in cervical cancer","volume":"120","author":"Chuk","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.003_bib0015","first-page":"1807","article-title":"2018 FIGO staging classification for cervical cancer: added benefits of imaging","volume":"40","author":"Salib","year":"2020","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"key":"10.1016\/j.brachy.2024.11.003_bib0016","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ijrobp.2011.10.027","article-title":"Optimized planning target volume for intact cervical cancer","volume":"83","author":"Khan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.003_bib0017","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.brachy.2024.11.003_bib0018","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.brachy.2024.11.003_bib0019","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.prro.2020.04.002","article-title":"Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline","volume":"10","author":"Chino","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2024.11.003_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygyno.2023.11.014","article-title":"Dose and fractionation regimen for brachytherapy boost in cervical cancer in the US","volume":"180","author":"Hsieh","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2024.11.003_bib0021","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ygyno.2005.02.015","article-title":"Long-term results of high-dose rate brachytherapy in cervix cancer using a small number of fractions","volume":"97","author":"Souhami","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2024.11.003_bib0022","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5114\/jcb.2022.113058","article-title":"Single application hybrid interstitial brachytherapy for cervical cancer: an institutional approach during the COVID-19 pandemic","volume":"14","author":"Damast","year":"2022","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2024.11.003_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106336","article-title":"Elimination of cervical cancer in U.S. Hispanic populations: Puerto Rico as a case study","volume":"144","author":"Ortiz","year":"2021","journal-title":"Prev Med"},{"key":"10.1016\/j.brachy.2024.11.003_bib0024","first-page":"15","article-title":"High-dose-rate brachytherapy boost for locally advanced cervical cancer: oncological outcome and toxicity analysis of 4 fractionation schemes","volume":"32","author":"le Guyader","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.brachy.2024.11.003_bib0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brachy.2022.11.005","article-title":"Comparing dosimetry of locally advanced cervical cancer patients treated with 3 versus 4 fractions of MRI-guided brachytherapy","volume":"22","author":"Scott","year":"2023","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.11.003_bib0026","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ijrobp.2019.12.019","article-title":"Ring versus ovoids and intracavitary versus intracavitary-interstitial applicators in cervical cancer brachytherapy: results from the EMBRACE I study","volume":"106","author":"Serban","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2024.11.003_bib0027","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ygyno.2022.06.019","article-title":"Clinical outcome of combined intracavitary \/interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer","volume":"166","author":"Rogowski","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2024.11.003_bib0028","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.semradonc.2019.08.007","article-title":"The cost-effectiveness and value proposition of brachytherapy","volume":"30","author":"Vu","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.brachy.2024.11.003_bib0029","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.brachy.2019.07.001","article-title":"How might financial pressures have impacted brachytherapy? A proposed narrative to explain the declines in cervical and prostate brachytherapy utilization","volume":"18","author":"Schad","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.11.003_bib0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.brachy.2018.12.002","article-title":"Understanding the underutilization of cervical brachytherapy for locally advanced cervical cancer","volume":"18","author":"Ma","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.11.003_bib0031","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2013.05.033","article-title":"Trends in the utilization of brachytherapy in cervical cancer in the United States","volume":"87","author":"Han","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.11.003_bib0032","doi-asserted-by":"crossref","first-page":"e1958","DOI":"10.1200\/OP.21.00291","article-title":"Socioeconomic and racial determinants of brachytherapy utilization for cervical cancer: concerns for widening disparities","volume":"17","author":"Boyce-Fappiano","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.brachy.2024.11.003_bib0033","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ijrobp.2015.08.036","article-title":"Impact of insurance status on radiation treatment modality selection among potential candidates for prostate, breast, or gynecologic brachytherapy","volume":"93","author":"Grant","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124004537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124004537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T12:14:14Z","timestamp":1737634454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472124004537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1538472124004537"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2024.11.003","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and dosimetric outcomes of a 3-fraction high-dose-rate brachytherapy boost for the treatment of locally advanced cervical cancer in a safety net hospital","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2024.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}